Do I have a leiomyosarcoma (LMS) or a large uterine leiomyoma (fibroid)?

Distinguishing Leiomyosarcoma from Large Fibroid

You most likely have a benign fibroid, as leiomyosarcomas are extremely rare (0.1% of all uterine tumors), but definitive diagnosis requires MRI evaluation and ultimately pathologic examination if concerning features are present 1.

Understanding the Probability

The overwhelming likelihood favors a benign leiomyoma:

• Fibroids affect up to 70% of women by menopause 1
• Leiomyosarcomas comprise only 0.1% of all uterine tumors 1
• Even among women undergoing surgery for presumed fibroids, only 1 in 350 have unsuspected sarcoma 2

However, risk increases significantly with age—1.7% of women in their seventh decade undergoing hysterectomy for fibroids actually have leiomyosarcoma 1.

Critical Distinguishing Features

Clinical Red Flags for Leiomyosarcoma:

• Postmenopausal status (sarcomas typically occur in older, postmenopausal women) 1
• Rapid growth, especially outside of pregnancy 1
• Growth after menopause (fibroids should shrink with declining estrogen)

MRI Features Suggesting Leiomyosarcoma:

Cross-sectional imaging, preferably MRI, is essential before any intervention 2. The 2018 ACR guidelines specifically recommend MRI after uterine artery embolization to exclude underlying leiomyosarcoma 2.

High-risk MRI features include 3, 4, 5, 6:

• Irregular or ill-defined margins (most discriminating feature with excellent interrater reliability)
• Intermediate to high T2 signal intensity (>50% of lesion brighter than myometrium)
• Restricted diffusion on DWI sequences
• Peripheral/heterogeneous contrast enhancement pattern
• Hemorrhage and necrosis
• Local lymphadenopathy or ascites

Benign fibroid features 3, 4:

• Well-defined, smooth margins
• Low T2 signal intensity
• Homogeneous appearance
• Uniform enhancement

Recommended Diagnostic Algorithm

1. Obtain contrast-enhanced pelvic MRI with DWI if not already done 2, 7, 8, 6

   • One study demonstrated 100% sensitivity and 97% specificity for prospective LMS identification using standardized MRI protocol 8

2. Age-based risk stratification:

   • Premenopausal: Tumors should be considered benign for practical purposes, but careful pathologic examination still required 1
   • Postmenopausal: Higher index of suspicion warranted

3. If MRI shows concerning features: Plan for en bloc hysterectomy without morcellation 9, 10

   • Morcellation is strongly discouraged due to high risk of worsening prognosis if malignancy is present 9

4. If MRI shows reassuring features: Conservative management or minimally invasive treatment options appropriate

Critical Pitfall to Avoid

Leiomyosarcoma is clinically indistinguishable from benign leiomyoma 1. Frozen section cannot reliably diagnose malignancy because mitoses are difficult to identify; permanent sections are required 1. Therefore, any procedure resulting in potential tumor spillage (like morcellation outside endoscopic bags) must be avoided when malignancy cannot be confidently excluded 9.

Definitive Diagnosis

Only histopathologic examination provides definitive diagnosis 1. Histologic criteria for malignancy include:

• Increased mitoses
• Cellular pleomorphism
• Thrombotic degeneration within the tumor

The combination of MRI conventional features, clinical data (especially age), and radiomics features achieves the best predictive ability (AUC 0.989), though conventional MRI and clinical data alone perform nearly as well (AUC 0.956) 5.